10.1101/sqb.1986.051.01.032 [DOI] [PubMed] [Google Scholar] Nagel S., Genius J., Heiland S., Horstmann S., Gardner H., Wagner S
[DOI] [PMC free article] [PubMed] [Google Scholar] 43.Khnast S., Van Der Tuin S.J.L., Van Der Hoorn J.W.A., Van Klinken J.B., Simic B., Pieterman E., Havekes L.M., Landmesser U., Lscher T.F., Van Dijk K.W., et al
Toxicology 218 , 229236 (2006)
The fat loss peptide category includes several compounds that address visceral fat through different mechanisms, and matching the right peptide to the right problem makes all the difference in outcomes
Among patients with postpartum thyroid dysfunction, the most common type is destructive thyrotoxicosis and simple symptomatic treatment, using beta-adrenergic--antagonists, is usually sufficient(109)